The medication is manufactured only by Novo Nordisk
Disclaimer: BPC-157 is not approved by the FDA for any medical application
In most cases, the symptoms improve as the body adjusts to the medication
In addition, a dose-dependent relationship between circulating TMAO and obesity has been found in apparently healthy individuals (Schugar et al., 2017)
Arthritis Rheumatol (Hoboken NJ) (2020) 72(12):20309
Randomised controlled trials involving GLP-1RA have not detected suicidality signals, but these studies were underpowered to detect rare events such as SIS, and they selectively exclude individuals with psychiatric comorbidity [23,24,25,26], which are prevalent in daily practice